GlassScriptPhysician profile
Jean M Linder
NPI 1962498428
$1,098.40
in general payments reported to CMS, 2019-2025
18 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $97.13 · 2021: $143 · 2022: $45.71 · 2023: $83.54 · 2024: $72.63 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $239.89 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Pfizer INC. | $181.16 | 2019-2025 | |
| Glaxosmithkline, LLC. | $106.09 | 2019-2025 | Shingrix |
| Edwards Lifesciences Corporation | $81.34 | 2019 | |
| Novo Nordisk INC | $76.86 | 2021-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $76.28 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $63.88 | 2019-2021 | |
| Abbvie INC. | $40.75 | 2021 | |
| Astellas Pharma US INC | $36.21 | 2019-2020 | |
| Lilly USA, LLC | $29.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.52 | 2019 | |
| Abbott Laboratories | $25.37 | 2022 | |
| Sanofi Pasteur INC. | $24.94 | 2019 | |
| Allergan, INC. | $24.81 | 2019-2020 | |
| Medtronic, INC. | $24.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.01 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Linder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.